KB

Kalpanaben Bhaskerbhai Vyas

Director Director DIN 03458016
DIN 03458016 First appointment May 2011 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since May 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Kalpanaben Bhaskerbhai Vyas

Data last updated:

Kalpanaben Bhaskerbhai Vyas was a Director at Apl Institute Of Clinical Laboratory & Research Private Limited (2011–2014). The company operates in Healthcare.

DIN 03458016
Primary Designation Director
Industry Healthcare
First Appointment 07 May 2011

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 May 20112011₹6.17 Cr (FY 2022)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Apl Institute Of Clinical Laboratory & Research Private Limited
Premium access

Shareholding and investment profile for Kalpanaben Bhaskerbhai Vyas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kalpanaben Bhaskerbhai Vyas

Kalpanaben Bhaskerbhai Vyas was first appointed on 07 May 2011 as Director at Apl Institute Of Clinical Laboratory & Research Private Limited.

Kalpanaben Bhaskerbhai Vyas held 1 earlier board appointment: Apl Institute Of Clinical Laboratory & Research Private Limited (Director, 07 May 2011 to 25 Mar 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available